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Abstract
The optic nerve, also known as the second cranial nerve, is composed of axons that trans-
mit visual information from the neurosensory retina to the visual cortex. There are mul-
tiple pathologies that can affect the human optic nerve. Congenital anomalies of the optic 
nerve include myelinated nerve fibers, morning glory syndrome, optic nerve choristoma, 
optic nerve coloboma, optic nerve hypoplasia and aplasia, and others. Tumors that can 
affect the optic nerve (ON) may occur primarily from within the nerve itself, from the sur-
rounding optic nerve sheath (ONS), or secondarily spreading to the nerve from a distant 
site. They include optic pathway glioma, medulloepithelioma, oligodendroglioma, optic 
nerve sheath meningioma, and others. Here in this chapter, we will review the optic 
nerve anatomy, embryology, and physiology in addition to assessment of optic nerve 
function. Moreover, the clinical features, imaging findings, pathology, and treatment 
options of the most common and some rare congenital anomalies and primary tumors of 
the ON and sheath will be reviewed.
Keywords: myelinated nerve fibers, morning glory syndrome, optic nerve 
choristoma, optic nerve coloboma, optic nerve hypoplasia, aplasia, optic nerve tumor, 
glioma, meningioma, ganglioglioma, medulloepithelioma, hemangioblastoma, 
oligodendroglioma
1. Introduction
Visual perception occurs when light stimulus in the surrounding environment converts to 
nerve impulses at the level of photoreceptors, which then reach the brain to be processed. 
The light energy is converted to neuronal signals that are transmitted through several layers 
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in the retina to reach the ganglion cells. The axons of the ganglion cells form the optic nerve. 
Signals are carried out from the optic nerve through the optic chiasm and optic tract, which 
is connected to the lateral geniculate body. From there, signals reach the visual cortex in the 
occipital lobe through the optic radiation.
The chapter is divided into three main sections. Section 1 describes the basic embryology, 
anatomy, and physiology of the optic nerve. Section 2 briefly discusses optic nerve develop-
mental anomalies, and the last section briefly reviews the most common optic nerve tumors 
and discusses their management modalities.
2. Optic nerve embryology, anatomy, physiology, and function
2.1. Optic nerve embryology
The optic nerve has a neural ectoderm origin. It develops within the optic stalk, which appears 
by 22–28 days of gestation. The optic stalk connects the optic vesicle to the cavity of the fore-
brain [1]. It has two layers, the inner layer is the axons of the ganglion cell layer and the outer 
layer is a neuroglial supporting cells. At 8 weeks of gestation, neuroepithelial cells including 
astrocytes and oligodendrocytes proliferate and participate in the formation of the connective 
tissue and myelination of the optic nerve. Myelination starts centrally and reaches the lamina 
cribrosa at or shortly after birth [2].
2.2. Optic nerve anatomy and physiology
The nerve fiber layer in the retina is the ganglion cell axons, which are generally unmyelin-
ated and receive blood supply from the central retinal artery. Ganglion cell axons turn 90° 
to enter the optic disc, where they form the optic nerve. The optic disc is supplied by a ring 
of branches from the short ciliary arteries called the circle of Zinn. Peripapillary arteries also 
contribute to the optic disc blood supply. The optic nerve consists of 1.2 million fibers with 
different sizes of diameter, ranging from 0.7 to 10 μm. Smaller fibers serve the central vision, 
while larger ones come from the peripheral retina [3]. The macular fibers are deep in the 
center of the optic nerve, while the fibers of the peripheral retina are more superficial.
The length of the optic nerve is around 6 cm and can be divided anatomically into four 
segments: intraocular (0.7–1 mm), intraorbital (30 mm), intracanalicular (6–10 mm), and 
intracranial (10–16 mm). The lamina cribrosa divides the intraocular part into prelaminar 
and laminar sections [4]. It is important to note that this part of the nerve is not myelinated. 
Oligodendrocytes are responsible for the myelination of nerves, and it is believed that the 
lamina cribrosa acts as a barrier preventing them from myelinating the intraocular section of 
the optic nerve [5].
Beyond the lamina cribrosa, the optic nerve is myelinated and surrounded by a dural sheath 
and cerebrospinal fluid. The extraocular muscles surround the optic nerve in the orbit. The 
optic nerve sheet is adherent to the superior and medial rectus muscle, hence the pain with 
eye movement when the optic nerve is inflamed in cases such as optic neuritis. The ophthal-
mic artery is the first branch from the internal carotid artery, and it forms the main blood 
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supply for intraorbital and intracanalicular division of the optic nerve. The ophthalmic artery 
passes through the dural sheath of the optic nerve in the intracanalicular section. The intra-
cranial optic nerve division is supplied by branches from the ophthalmic, interior cerebral, 
anterior communicating, and internal carotid arteries. Ninety percent of the optic nerve fibers 
from both sides join in the optic chiasm, while the remaining 10% of fibers project to areas 
controlling pupillary responses [5].
2.3. Assessment of optic nerve function
The optic nerve function is assessed by evaluating several elements including the visual acu-
ity, color vision and contrast testing, relative afferent pupillary defect in cases of asymmetric 
optic neuropathy, and visual field testing. These parameters should be evaluated in every 
patient with suspected optic neuropathy. In addition, electrophysiological testing is another 
adjunctive test used to assess optic neuropathies.
2.3.1. Visual acuity (VA)
Visual acuity is a vital function of the optic nerve and an important measure of the visual func-
tion. The smallest visual angle at which two distinct objects can be distinguished is referred 
to as the minimum separable threshold. The best-corrected visual acuity (BCVA) should be 
obtained with refraction to exclude any refractive errors. The physician can expect a refractive 
error when there is an improvement of visual acuity with pinhole viewing.
Snellen acuity is measured with test letters (optotypes), and they are designed in a way so that 
the letter as a whole subtends an angle of 5 min of arc at a specified distance. A 20/40 Snellen 
acuity (6/12 in m) means that the patient can see the 20/40 line 20 feet away from the chart 
what a normal person can see clearly 40 feet away.
2.3.2. Color vision
Optic nerve diseases, especially optic neuritis, may disproportionately affect color vision 
compared with BCVA. In macular disease, however, both visual acuity and color vision tend 
to be affected congruently. In addition, color vision deficit (dyschromatopsia) can persist even 
after recovery of visual acuity in optic neuropathy.
Color vision testing is done monocularly. Pseudoisochromatic color plate is widely avail-
able and frequently used to evaluate color vision. Bilateral, symmetric, color vision deficit 
in males may indicate congenital dyschromatopsia. The most detailed color vision test is the 
Farnsworth-Munsell 100-hue test. It uses 85 colored discs, and thus, it needs a considerable 
amount of time that limits its use in routine clinical practice.
2.3.3. Contrast sensitivity
Contrast sensitivity is simply defined as the ability to recognize the degree of contrast 
between the optotype and its background. The higher the contrast, the easier the optotype 
is to be seen. Increasing the illumination makes it easier to read because this creates a higher 
contrast against the black letters. Snellen acuity optotypes are projecting at approximately 
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100% contrast that can be resolved more easily by the visual system. However, 100% con-
trast is rarely encountered in everyday life, and therefore, 20/20 vision does not always 
mean good vision as low-contrast sensitivity may significantly compromise the visual 
quality.
Contrast sensitivity testing can detect and quantify vision loss in the presence of normal visual 
acuity. The Pelli-Robson contrast sensitivity letter consists of rows of letters of equal size but 
with decreasing contrast for groups of three letters. Sinusoidal gratings require the test subject 
to view a sequence of increasingly lower contrast gratings. Many conditions reduce contrast 
sensitivity. They include optic neuropathy, posterior subcapsular cataracts, and amblyopia. 
Contrast sensitivity testing is not commonly used in clinical practice.
2.3.4. Pupillary examination
Pupillary examination and particularly testing for relative afferent pupillary defect (RAPD) 
is highly sensitive for optic nerve diseases. Under normal conditions, light source directed 
at one pupil causes symmetric ipsilateral and contralateral pupillary constriction (direct and 
consensual response). When the optic nerve of one eye is damaged or inflamed more than 
the other eye, a relative afferent pupillary defect is seen in the more affected eye. In other 
words, shining the light over the normal, or less affected, eye will result in bilateral pupillary 
constriction. However, when the light is swung to the more affected eye, we will see a bilateral 
pupillary dilation as the signal conduction along the optic nerve is relatively compromised 
compared to the other eye.
An absence of RAPD usually indicates a bilaterally normal optic nerves or a bilateral sym-
metric optic neuropathy. RAPD can be seen in patients with significant retinal dysfunction 
including central retinal artery occlusion, ischemic central retinal vein occlusion, or retinal 
detachment.
2.3.5. Visual field
Visual field is another important function of the optic nerve in which a visual field defect 
testing can describe, quantify, monitor, and localize the different patterns of visual loss. There 
are different techniques available to evaluate visual field. The choice of technique depends on 
the degree of detail required and the cooperation of the patient.
Confrontation visual field testing is a simple test that can be done at the bedside or in the 
clinic providing a gross evaluation of the visual fields. The examiner sits 1 m from the patient. 
The patient is asked to cover one eye and fixate on the examiner’s nose by the other eye. 
Then, the examiner requests the patient to identify the numbers (1, 2, or 5) presented by the 
examiner’s fingers at the midpoint of each of the four quadrants for each eye.
A more detailed evaluation of the visual field is assessed by perimetry. There are two main 
types: static and kinetic perimetry. In static testing, stimuli are static and turn on and off at 
different points within area the visual field to be tested. In kinetic testing, a stimulus is moved 
from a nonseeing peripheral area to a seeing area of the visual field. In kinetic testing, an 
isopter is drawn by connecting all points of equal sensitivity for a specific stimulus.
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2.3.6. Visual evoked potentials (VEP) in the assessment of optic nerve function
Visual evoked potential (VEP) is an electrical response recorded mainly from the visual cortex 
in response to light stimulus. It was first introduced in 1930s, and its role has evolved over the 
years [6]. In 1961, Ciganek was the first to describe an electroencephalography (EEG) response 
to a flashlight stimulus in humans, followed by one of the earliest clinical studies of VEP 
reported by Halliday and colleagues on patients with optic neuritis [7, 8].
VEP provides an objective and reproducible measure of visual function and continues to have 
an imperative complementary role to other tests that provide information on the structure of 
the visual system such as MRI and optical coherence tomography (OCT).
The recording of VEP is performed using occipital mounted electrodes with, typically, monocu-
lar stimulation. Several forms of visual stimulus can be used to generate a VEP. The most com-
mon stimuli used are flash visual evoked potential (fVEP), pattern-onset VEP, and reversing 
black and white checkerboard pattern (PVEP). Because of fVEP’s high intersubject variability 
and low sensitivity, PVEP is preferred in most clinical sitting. fVEP is frequently used in infants, 
uncooperative patients or if significant media opacity is present. The pattern-onset VEP is pre-
ferred in patients with fixation instability such as nystagmus since the PVEP is severely reduced 
in those patients due to the effect of retinal image motion on the stimulus efficiency [9, 10].
The testing technique for both stimulus conditions has been standardized by the International 
Society of Clinical Electrophysiology of Vision (ISCEV) to reach a better consistency of results 
between different electrophysiology laboratories [11]. The PVEP waveform is triphasic with 
a prominent positive peak (P100) at around 100 ms, an earlier negative peak at around 75 ms, 
and a late negative peak at around 135 ms after stimulation (Figure 1). The amplitude of 
the P100 reflects the number of functional afferent axons reaching the cortex. The implicit 
time (latency) is believed to reflect the degree of demyelination. An abnormal VEP response 
Figure 1. Normal waveform of a standard PVEP. Arrows showing first negative peak (N75), positive peak (P100), and a 
late negative peak (N135).
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indicates a functional disturbance in the afferent visual pathway, and occasionally, conven-
tional VEP may provide some information on the location of the lesion [12]. For example, 
based on the neuroanatomy of the visual system, a unilateral VEP abnormality implies an 
abnormality in the anterior optic pathway. Localization is less likely when the delay is bilateral.
3. Developmental anomalies of the optic nerve
3.1. Myelinated nerve fibers
The prevalence of myelinated nerve fibers (MNF) is around 1% in autopsy studies [13]. MNF 
are typically congenital, and therefore likely represent anomalies of myelination control in 
utero. They appear as gray or white striated patches with feathered borders, which are most 
commonly unilateral, with only 7.7% of cases estimated to occur bilaterally (Figure 2) [13, 14]. 
The mechanism by which MNF occur might be linked to unknown level of communication 
between adjacent oligodendrocytes (which are responsible for myelinating the axons of sub-
sets of neurons in the central nervous system) in the selection of axons for myelination [15]. 
Recently, a case of bilateral extensive peripapillary MNF has been reported in a patient with 
Crouzon syndrome, an inherited form of craniosynostosis caused by over-activation of fibro-
blast growth factor receptor 2 [16].
3.2. Morning glory syndrome (MGS)
MGS is a rare congenital optic disc anomaly, first reported by Pendler [17] then more accu-
rately described 10 years later [18]. The pathogenesis of MGS is uncertain, but probably is 
an embryological form of optic disc dysplasia and is thought not to be a true coloboma, but 
rather a posterior ectasia, which is the consequence of developmental disturbance of sclera 
[19, 20]. MGS is characterized by a funnel-shaped enlarged optic disc with a central mass of 
glial tissue and emerging radial retinal vessels that emerge from the central core toward the 
peripheral retina (Figure 3) [21]. MGS is a nonprogressive and untreatable condition, which 
Figure 2. Myelinated nerve fibers (MNF).
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usually occurs as an isolated ocular anomaly, or can also be associated with other ocular 
abnormalities such as strabismus, afferent pupillary defect, visual field defects, preretinal 
gliosis, and open angle glaucoma [22–25]. The optic nerve has been reported to present with 
characteristics of coloboma, hypoplasia, and morning glory anomaly, as an overlapping phe-
notypic profile that has been described in relation to PAX6 mutations, which influences the 
phenotypes of optic nerve malformations [26].
3.3. Optic nerve choristoma
Choristoma is an uncommon congenital tumor where normal-looking tissue (epithelial, glan-
dular, cartilaginous, osseous, smooth muscle, and fat) is present in an area where it should not 
be normally present. Most ocular choristomas are periocular but can also be rarely found as 
an intraocular choristoma involving the iris, ciliary body, choroid, and optic nerve head [27]. 
The largest series on optic nerve choristomas in the English literature was published in 1972 
including 26 cases of optic nerve colobomas in enucleated eyes, and all cases were diagnosed 
to have associated heterotopic adipose and/or smooth muscle tissue on pathological examina-
tion. The age at enucleation ranged from 6 weeks to 70 years [28]. An interesting case present-
ing with mixed clinical features of optic nerve coloboma and morning glory—as previously 
described by others—has been reported by Mishra but unexpectedly had histopathological 
evidence of a choristoma [29, 30]. The authors commented that there is insufficient knowledge 
in the literature about the natural history and outcome of optic nerve choristoma, but their 
15-year old girl has shown dramatic rapid deterioration of vision. They attributed this to the 
abnormal architecture of the colobomatous nerve that resulted in the patient’s vulnerability 
to the critical growth of the choristomatous tissue during adolescence, on the top of the slow 
axonal loss from the choristoma, as evident by the pallor of the optic nerve head at the time 
of presentation [30].
3.4. Optic nerve coloboma
Ocular coloboma occurs in relation to the failure of the closure of the embryonic fissure that 
results from the evagination of the developing optic vesicle during embryogenesis and eye 
development. The fissure is located inferiorly and includes the optic stalk (future optic nerve) 
Figure 3. Morning glory syndrome.
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that connects the developing forebrain to the eye. The extent of the colobomatous defect 
depends on the location of the arrested closure of that fissure. Colobomas in the eye can be 
seen anteriorly involving the iris and ciliary body or posteriorly involving the optic nerve. 
The optic nerve coloboma appears as a sharp whitish excavation inferiorly with a thin neu-
roretinal rim and may even extend to involve the adjacent choroidal and retinal tissue. Optic 
disc colobomas can occur bilaterally, can be sporadic, or can have an autosomal dominant 
inheritance. Ocular coloboma is known to show extensive locus heterogeneity associated 
with causative mutations identified in genes encoding developmental transcription factors 
or components of signaling pathways that are involved in the posterior segment develop-
ment as a whole. Optic nerve coloboma can be associated with similar colobomatous ante-
rior uveal or posterior chorioretinal defect as well as possible more extensive manifestations 
(anophthalmia/microphthalmia) related to the defective and/or failure of embryonic fissure 
closure [30]. The term microphthalmia is used to indicate the marked reduction in the size 
of an eye. Microphthalmia, anophthalmia, and coloboma resulting from failure of optic fis-
sure closure during embryogenesis have been grouped as a single phenotype or spectrum 
(MAC) in most of the recent studies aiming at identification of responsible genes [31, 32]. 
Heterozygous loss-of-function mutations in SOX2, PAX6, and OTX2 (involving dosage-sensi-
tive transcription factors) are the most common genetic pathology associated with severe eye 
malformations (anophthalmos/severe microphthalmos) [33–36], and bi-allelic loss-of- func-
tion in STRA6, ALDH1A3, and RARB (related to the regulation of retinoic acid metabolism 
or transport) is confirmed as an emerging cause of nonsyndromic eye malformations [37–40]. 
In the coloboma/microphthalmia patients, Prokudin reported other variants in CYP1B1 that 
are emerging with CYP1B1 being considered a possible candidate gene as a modifier in colo-
boma/microphthalmia [41] and commented on the heterogeneity and the complex pattern 
associated with MAC phenotype. This is nicely summarized by Reis and Semina [32]. Two 
novel heterozygous SOX11 variants were identified in patients with coloboma [42]. In gen-
eral, an identifiable genetic cause is found by molecular genetic testing in 80% of individuals 
with bilateral anophthalmia/severe microphthalmia and in up to 20% of individuals with an 
ocular malformation in the MAC spectrum [43]. Microphthalmos is one of the ocular anoma-
lies described in fetal alcohol syndrome, which causes multiple teratogenic effects on ocular 
embryogenesis [44]. Lenz microphthalmia syndrome (LMS) is a specific entity characterized 
by unilateral or bilateral microphthalmia and/or clinical anophthalmia with malformations of 
the ears, teeth, fingers, skeleton, and/or genitourinary system in addition to coloboma, which 
is present in 60% of microphthalmic eyes. The coloboma ranges from simple iris coloboma 
to coloboma of the ciliary body, choroid, and ON. The diagnosis of LMS depends on clinical 
findings; however, molecular testing showed that NAA10 and BCOR (BCL6 corepressor) are 
known to be associated with LMS.
3.5. Optic nerve aplasia
Optic nerve (ON) aplasia is a rare developmental anomaly that implies complete absence 
of the ON including the disc and is usually seen in unilateral deformed globe in a healthy 
person with no hereditary predisposition. There are only three previous reports of bilateral 
ON aplasia in otherwise normal children [45–47]. The radiological finding of thinned ON 
indicates the presence of ON sheath with some glial tissue and can aid in the diagnosis. In 
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the most recent case, flash visually evoked potentials (VEP) was performed to distinguish ON 
hypoplasia from ON aplasia and VEP was not recordable [47]. The ON is formed of axons 
of the retinal ganglion cells, which form the ON that is derived embryologically from the 
inner neuroblastic layer of the optic cup, and failure of development of these cells is rare [48]. 
When there is accompanying failure of development of mesodermal elements as well, it is 
termed aplasia of the ON, which is defined as an absence of optic nerve, ganglion cells, and 
central retinal vessels [28, 49]. Many previously reported cases in literature as ON aplasia are, 
actually, cases of ON hypoplasia because of some overlapping features [50]. Variable oph-
thalmic features associated with ON aplasia include microphthalmos, enophthalmos, ptotic 
lids, squint, microcornea, trabeculodysgenesis, iris hypoplasia, iris coloboma, aniridia, and 
persistent hyperplastic primary vitreous [28, 49].
3.6. Optic nerve hypoplasia (ONH)
Unilateral ONH is a congenital disorder characterized by an underdevelopment of one of the 
ONs with marked intracranial asymmetry. Clinically, the ON head looks small with a charac-
teristic “double-ring sign” (Figure 4). Visual acuity ranges from 20/20 to amaurosis presenting 
variable visual field defects but the visual impairment is nonprogressive. The diagnosis of 
ONH is typically clinical, but the confirmation is more accurately established by MRI [51, 52]. 
Several associations have also been reported between ONH and central nervous system (CNS) 
anomalies: such as septo-optic dysplasia (SOD), which is a heterogeneous inconstant combina-
tion of different CNS parenchymal malformations: ONH, pituitary hypoplasia (with hormonal 
deficiency), and midline malformations of the brain (absence of the septum pellucidum or thin-
ning of the corpus callosum) [52]. On the other hand, several anomalies have been reported in 
fetal alcohol syndrome including optic nerve hypoplasia in 48%, and abnormal tortuosity of 
retinal arteries in 49% in addition to anterior segment anomalies such as microcornea, cataract, 
and iris defects in 10% [53]. The ONH is thought to occur because of the teratogenic of alcohol 
on the developing optic nerve at sixth week of gestation when the first retinal ganglion cells 
first appear until after birth [44]. It is recommended to perform neuroimaging when ONH is 
Figure 4. Bilateral optic nerve hypoplasia in a patient with septo-optic dysplasia.
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detected to rule out other associated CNS anomalies and internal carotid artery hypoplasia, 
which has been recently reported advocating the theory of vascular disruption sequence at the 
time of neuroembryogenesis and restriction of intrauterine blood supply as the cause for ONH 
[54]. Patients with ONH should also have endocrinological work-up to rule out de Morsier 
syndrome since hypothalamic/pituitary dysfunction has been found in 69% of unilateral cases 
and 81% in bilateral [55, 56]. ONH has been reported in association with Down’s syndrome in 
the United States [57]. Optic nerve dysplasia and vascular anomalies have also been found in 
4–38% of patients with Down’s syndrome in emerging countries [58, 59]. Afifi and co-authors 
also reported tilted (dysplastic) optic nerve heads in two cases out of their studied series of 
Down’s syndrome children but related their finding to an associated myopia in the same 
two patients [60]. ONH is the most common congenital ON anomaly and a major cause of 
blindness in the USA, and even though most cases are isolated, the new molecular diagnostic 
techniques have recently raised the fact that a significant portion of ONH cases has underlying 
genetic causes, typically de novo mutations [61] Also, two missense mutations in SALL4 were 
found in a patient with bilateral ONH, unilateral microphthalmos, and coloboma, in addition 
to cardiac septal defects and delayed growth. SALL4 is expressed in the developing lens and 
regulates BMP4; therefore, authors speculated that altered BMP4 expression is the cause for 
the eye anomalies [62]. Finally, it has been suggested to perform behavioral assessment in 
ONH children who have mild to moderate or even no visual impairment [63].
3.7. Optic tract hypoplasia
Congenital optic tract hypoplasia is rare and most of the optic tract abnormalities are acquired 
[64]. They are usually attributed to tumor, hemorrhage, aneurism, and CNS demyelinating 
disease, while some are associated with anophthalmos. Isolated optic tract aplasia/hypoplasia 
was reported in three cases, all of which are unilateral [65–67].
Figure 5. Tilted disc syndrome.
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3.8. Optic nerve (ON) tilt
ON tilt has been described in association with myopia and more strongly in association with 
the presence of crescent regardless of the refractive error (Figure 5). Crescent was observed 
approximately five times more frequently in myopic eyes when compared with nonmyopic eyes 
(49 vs. 10%), and the median degree of tilt was about double (6.08 vs. 2.48). Ethnicity was also 
strongly associated with tilt and crescent, with ON heads in Asian eyes having the most tilt [68].
4. Primary tumors of the optic nerve
4.1. Optic pathway glioma (OPG or pilocytic astrocytoma)
Optic pathway gliomas (OPGs) comprise tumors that arise from the visual pathway includ-
ing the optic nerve (ON) and chiasm. Tumors that only affect the ON are referred to as optic 
nerve gliomas (ONGs). In general, OPGs are uncommon and account for only about 1% of 
intracranial tumors [69]. However, they are the most common primary tumors of the optic 
nerve, comprising about 65% of all intrinsic ON tumors [70].
More than two-thirds of OPGs are detected in the first decade of life and up to 90% before 
the end of the second decade [69]. The median age of diagnosis of ONGs is 6.5 years with an 
age range of 2–46 years. Whereas the median age of chiasmal gliomas is 11 years with an age 
range of 0.75–50 years [71]. There is no sex predilection. Those lesions are considered hamar-
tomas by some authors. ONGs are considered by the 2016 World Health Organization (WHO) 
as low-grade I juvenile pilocytic astrocytomas or grade II diffuse fibrillary astrocytomas [72].
ONGs are most often benign and slowly growing. The most common presenting findings in 
descending order are proptosis (94%), vision loss (87.5%), optic disc pallor (59%), disc edema 
(35%), and strabismus (27%) [69]. However, the presentation of ONGs is variable and mostly 
depends on the segment of the optic nerve affected by the tumor. The “anterior” involvement 
presents with signs of an anterior optic neuropathy and is more likely to be associated with 
optic disc swelling. The “posterior” involvement is associated with either normal or pale optic 
disc. Patients infrequently present with isolated optic atrophy. A relative afferent pupillary 
defect (RAPD) is usually present in unilateral or asymmetric cases with affected visual field. 
The occurrence of nystagmus represents severe visual loss. The nystagmus is monocular, ver-
tical, of low-frequency and variable amplitude. This can differentiate it from spasmus nutans, 
which is known to be seen in gliomas that involve the optic chiasm [73]. Other rare presenta-
tions of ONGs include central retinal vein occlusion (CRVO), retinochoroidal collaterals, or 
neovascular glaucoma (NVG) [74].
Most cases of ONGs are sporadic. However, there is a clear genetic relationship between ONGs 
and neurofibromatosis type 1 (NF1). NF1 is an autosomal dominant disorder that occurs in 
1 in 3000 individuals. It is caused by a mutation in the gene coding for neurofibromin, a tumor 
suppressor gene, situated in chromosome 17. About 8–31% of NF1 patients have ONGs. On 
the other hand, 10–70% of patients with ONGs have NF1 [75]. The wide range of incidence 
can be explained by referral bias, radiologic detection rate, and the used diagnostic criteria.
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The etio-pathogenesis for the development of gliomas in patients with NF1 is related to the acti-
vation of the retro-virus-associated sequence (RAS) oncogene (that is inhibited by neurofibromin 
in normal individuals) and the B1 homolog of the retrovirus-associated function (BRAF) onco-
gene [73]. The end result is increased protein synthesis and glial cell proliferation. The associa-
tion between NF1 and the behavior of the glioma is poorly understood. Classically, optic nerve 
gliomas in patients with NF1 have a more benign prognosis, although this concern is unresolved 
[69]. Rarely, ONGs can be found in patients with neurofibromatosis type 2 (NF2) [76]. In addi-
tion, ipsilateral optic nerve glioma can occur in association with morning glory disc anomaly [77].
Regarding the radiologic findings (Figure 6), ONGs may show one of two patterns. The most 
common pattern is the classic fusiform swelling of the ON. In magnetic resonance imaging 
(MRI), they are hypo- or isointense in T1-weighted images, hyperintense in T2-weighted images, 
enhancing after intravenous injection gadolinium. The subarachnoid space (SAS) surrounding 
the ONGs is distended and thought to be occupied by trapped cerebrospinal fluid (CSF) in 
some patients. However, ultrasonographic examination in such cases characteristically discloses 
signs of solid component in the SAS. This indicates that the distension is most likely due to the 
spread of tumor into the SAS (the “pseudo-CSF sign”) and does not represent trapped CSF [78].
The second and less common radiologic pattern is the appearance of a thickened and 
kinked nerve in the portion affected by the ONG [75, 76]. Like the first pattern, enlarge-
ment of the subarachnoid space is due to extension of the tumor. It was suggested that this 
pattern (i.e., thickening and kinking) is more commonly observed in patients with NF1 and 
the fusiform enlargement pattern is more commonly seen in patients with sporadic ONG 
[79]. Nevertheless, no pattern is indicative of a specific diagnosis as both can be seen in spo-
radic ONGs and ONGs related to NF1. In both patterns, the margin of the nerve is usually 
well defined and smooth due to an intact optic nerve sheath. This is a differentiating feature 
between ONG and optic nerve sheath meningioma (ONSM).
ONGs can either show an isolated involvement of the orbital portion of the optic nerve or 
combined involvement of both orbital and intracranial portions. The optic foramen may still 
be distended even if the ONG is restricted to the orbital or intracranial portion of the optic 
Figure 6. Optic nerve glioma. The left figure is a T2-weighted axial MRI showing left orbital and intraconal mass with 
high signal intensity. The right figure is a T1-weighted axial MRI showing postcontrast enhancement.
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nerve. This is caused by secondary meningeal hyperplasia traveling proximally (or distally) 
and not the tumor itself. Therefore, enlargement of the optic foramen is not a proof of intra-
cranial extension of an orbital ONG. Furthermore, the optic foramen may still be of normal 
diameter in the sitting of intracranial or chiasmal ONG [80]. Histopathologic examination 
performed on a resected ONG, which did not reveal spread intracranially by MRI as well as 
by gross examination, showed an evidence of intracranial spread [81].
Histopathologically (Figure 7), ONGs are characterized by three main patterns that may all be 
present in different cuts of the same tumor: A. Transitional area, in which the tumor blends into 
the normal tissue of optic nerve and shows more abundant and less arranged glial nuclei than 
in the normal nerve. Increased number and size of glial cells results in enlarged nerve bundles. 
B. Coarsely reticulated and myxomatous areas with microcystoid spaces perhaps representing 
tumor necrosis. C. Astrocytic areas, in which spindle cell formation with Rosenthal fibers, which 
are cytoplasmic and eosinophilic structures in astrocytes, are seen [80]. Immunohistochemically, 
the neoplastic astrocytes stain positively for glial fibrillary acidic protein, HNK-1 (type 1 astro-
cyte precursor marker), S-100, and vimentin. Thus, this suggests that type 1 astrocytes are the 
origin of the tumor [82]. ONGs nearly always remain confined to the dural sheath, but a spread 
into the subarachnoid space surrounding the nerve is not uncommon [75].
The diagnosis of an ONG is usually reached on the basis of the clinical signs and radiologic find-
ings. Biopsy of the lesion is largely not required because of the presence of high-resolution neu-
roimaging with enhanced diagnostic accuracy, biopsy of the sheath alone may show secondary 
meningeal hyperplasia seen in ONGs and falsely suggesting optic nerve sheath meningioma, 
and the low predictive value of the histologic appearance of the tumor in its clinical behavior 
[82]. Most importantly, the procedure could be complicated by permanent visual loss [83].
There is no universally recognized management for ONGs, and it should be individualized 
to the patient. ONGs are usually very slow growing tumors and some lesions will spontane-
ously regress. Therefore, observation is indicated for patients with reasonably good vision 
Figure 7. Histopathological appearance of an optic nerve pilocytic astrocytoma (Original magnification × 100 hematoxylin 
and eosin).
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and stable radiologic appearance on serial imaging [84, 85]. For patients presenting with 
reduced vision and particularly if it is deteriorating or there is a radiologic evidence of tumor 
growth, a number of treatment options exists.
Chemotherapy is evolving as an initial treatment modality for patients with severe or progres-
sive visual deterioration. It may be especially beneficial in children younger than 5 years of age. 
The recommended chemotherapeutic agents include vincristine, carboplatin, vinblastine, and 
temozolomide with remarkable outcomes observed in some patients [86]. Combining carbo-
platin and vincristine is the most accepted regimen [69]. Additionally, treatment with topical 
nerve growth factor improved the vision in patients with known or presumed ONGs. A 10-day 
course of topical murine nerve growth factor in five children with ONGs and severe optic disc 
pallor showed an increase in visual evoked potential amplitudes that lasted for 90 days in all 
patients [87].
Fractionated stereotactic radiotherapy is another option for some patients with ONGs and can 
be used as a monotherapy or adjunctive to other treatment modalities [88, 89]. It is usually 
kept for patients who are older than 5 years of age and, preferably, after puberty. Shrinkage 
of ONGs, with subsequent improvement in vision and halting of progressive visual loss, 
reduction in optic disc swelling, and decreasing proptosis have been reported in two studies 
[90, 91]. In contrast, a third study concluded that radiation of ONGs has no significant benefit 
in the overall outcome when compared to observation or surgical intervention [71]. Thus, 
radiotherapy is still controversial because of questionable results and possible complications 
including pituitary dysfunction and intellectual disabilities [69].
Surgical excision or debulking of ONGs may be indicated in patients with severe deteriora-
tion of visual function associated with cosmetically disfiguring proptosis [92, 93]. In some 
cases, optic nerve sheath fenestration is performed to release the trapped CSF surrounding 
the tumor. Surgery has been suggested to prevent progression into the intracranial optic 
nerve and chiasm. However, involvement of the chiasm is rare and prevention is not proven 
as the tumor was commonly found in the margins during histopathologic examination of the 
resected ONGs [82].
4.2. Malignant optic nerve glioma (malignant astrocytoma)
Malignant ONGs are rare neoplasms that involve the anterior visual pathway (i.e., proximal 
to the lateral geniculate nucleus). According to the WHO 2016, malignant ONGs are classified 
as grade III (anaplastic astrocytoma) or grade IV (glioblastoma) [72]. In contrast to ONGs 
mentioned above, malignant ONGs predominantly affects adults. The mean age of onset is 
57 years with an age range between 22 and 83 years. There is no gender predilection [94]. 
Patients present acutely with unilateral or bilateral orbital pain and progressive vision loss. 
The optic disc appearance can be either normal or pale in most cases although disc swelling 
and CRVO can also occur [75, 94].
MRI scan shows diffusely enlarged optic nerve, chiasm, or optic tract with heterogenous 
enhancement [69]. Histopathologically, malignant ONGs are show areas of anaplasia and 
are classified as anaplastic astrocytomas or glioblastoma multiforme [78]. Treatment involves 
radiotherapy, chemotherapy, or both but is rarely successful. The visual and the survival rate 
Optic Nerve70
are very poor. Blindness typically occurs 2 to 4 months after onset of vision loss and mortality 
from hypothalamic and brainstem involvement usually follows after 6–12 months [69].
4.3. ON medulloepithelioma
Medulloepithelioma refers to tumors arising from the cells of the primitive neural tube and 
the medullary plate. These tumors are extremely rare [95]. They can arise in any part of the 
central or peripheral nervous system [96, 97]. They may also arise from the globe, principally 
the ciliary body. Medulloepitheliomas arising from the optic nerve are very rare. Patients 
present with proptosis, progressive visual loss, disc swelling, and later disc pallor [73].
Imaging initially may show fusiform enlargement of the ON resembling an ONG [75]. 
At the time of surgery, the diagnosis of an ON medulloepithelioma is usually reached. 
Histopathologic examination of ON Medulloepithelioma shows hyperchromatic nuclei with 
high mitotic index. The neoplastic cells are arranged in tubes and cords. Hyaluronidase-
sensitive material is observed and stains positively with Alcian blue [75, 98, 99]. More dif-
ferentiated cells are arranged in rosettes [73]. Teratoid variants of medulloepithelioma have 
other elements such as striated muscle or cartilage [78, 98].
The most commonly used treatment modality is resection of the involved ON. Even with 
complete resection, however, recurrences and metastases can be seen. Therefore, other treat-
ment options include adjuvant radiotherapy, chemotherapy, or both [75, 99].
4.4. ON oligodendroglioma
Oligodendroglioma is a type of glioma that is believed to originate from oligodendrocytes. 
Up to 12% of all intracranial tumors are caused by oligodendrogliomas [100], and there is no 
gender predilection. They can affect individuals on all ages although they are more prevalent 
in middle aged adults. The most common location of oligodendrogliomas is in the cerebral 
hemispheres, particularly the frontal lobes. However, oligodendrogliomas of the cerebellum, 
the spinal cord, and the brainstem have been reported [101].
Histopathologically, compact masses of swollen oligodendrocytes were separated by an 
extremely thin stroma. Mitoses are generally rare and variable [100]. They have been reported 
to be associated with orbital non-Hodgkin lymphoma [102]. Another study described a case of 
a 14-year-old girl who presented with monocular progressive proptosis, vision loss, and lim-
ited extraocular muscle motility. Imaging showed a large fusiform enlargement of the orbital 
portion of the ON. Microscopic examination of the resected ON proved changes indicative of 
an oligodendroglioma [103].
4.5. ON ganglioglioma
As the name implies, gangliogliomas are composed of both ganglion cells and astrocytes. 
They are rare tumors and classified as grade I by the WHO [72]. Gangliogliomas of the ON 
have been described in few studies [104–106]. In noncontrast enhanced imaging, ON ganglio-
glioma resembles a benign ONG. However, gangliogliomas characteristically do not show 
enhancement on MRI after intravenous injection of gadolinium [104]. However, the diagnosis 
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of ON gangliogliomas is usually reached after microscopic examination that shows many 
ganglion cells with an increased population of glial cells. Treatment involves partial or total 
ON nerve resection and radiotherapy [73].
4.6. ON hemangioblastoma
ON hemangioblastomas may be sporadic or occur in the sitting of Von Hippel-Lindau disease 
(VHL). It is an extremely rare tumor, which affects males and females equally with an age 
of onset ranging from 15 to 44 years. Presentation includes vision loss, headaches or pain 
with ocular movement, and proptosis accompanied by optic disc swelling or pallor [107]. 
Radiologically, they look like ONGs except that hemangioblastomas show more homogenous 
enhancement. Histopathologically, these tumors are comprised of endothelial cells and peri-
cytes with variably sized vascular channels [73].
4.7. ON schwannoma
Schwannomas are benign tumors of peripheral nervous systems derived from Schwann cells. 
The vestibular location of the schwannoma is more frequent, followed by the involvement 
of the trigeminal nerve. In the orbit, schwannomas account for 1–6% of intraorbital tumors. 
Although it is theoretically impossible for a schwannoma to develop from the sheath of the 
optic nerve, which is devoid of Schwann cells, there are some exceptional cases of schwan-
noma of the nerve [108–111].
Several histopathogenic explanations have been reported. These include the presence 
of ectopic Schwann cells that may have migrated at the time of embryogenesis [110, 112]. 
Another explanation would be a transformation of the pial mesenchymal cells [112, 113]. A 
final hypothesis is that schwannoma does not develop from the sheath of the optic nerve but 
from sympathetic nerves running on it [75, 110]. T1-weighted MRI typically demonstrates a 
homogenously enhancing lesion. The complete excision of these tumors most often allows a 
definitive cure without recurrence [114, 115].
5. Primary tumors of the optic nerve sheath (optic nerve sheath 
meningioma)
The only tumor that can develop solely from the optic nerve sheath is optic nerve sheath 
meningioma (ONSM) [73]. ONSMs result from proliferations of the meningoepithelial cells 
covering the sheath of the intraorbital or intracanalicular optic nerve [69]. ONSMs are uncom-
mon, accounting for 1–2% of all orbital tumors [116–118]. However, ONSMs are the second 
most common cause of primary optic nerve and sheath tumors, second only to optic nerve 
glioma [69]. Moreover, 90% of all orbital meningiomas were secondary to intracranial exten-
sion and the remaining 10% were primary ONSMs [116].
Almost all ONSMs are unilateral although they may be bilateral especially in patients with 
NF2 [119]. ONSMs are typically discovered in adults during the fourth or fifth decade. Females 
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are affected three times as often as males. Up to 7% of all ONSMs occur in children [69]. A 
classification system of ONSMs was suggested and includes three types: type I ONSMs, in 
which the tumor involves the orbital portion of the ON manifesting as fusiform, tubular, or 
globular enlargement of the nerve; type II ONSMs, where the tumor extends through the 
optic canal or supraorbital fissure; and type III ONSMs, with more than 10-mm intracranial 
extension or involvement of the contralateral ON [120].
The classic diagnostic triad of ONSMs includes painless, slowly progressive, unilateral vision 
loss associated with optic atrophy, and retinochoroidal collaterals. These collateral vessels 
connect the retinal venous circulation to the choroidal venous circulation and are seen in 
approximately 30% of patients [69]. Transient visual obscuration may also occur. In addition, 
reduced color vision, visual field defect, an ipsilateral RAPD with variable proptosis and limi-
tation of ocular motility are observed [73]. The ON head maybe normal, swollen, or atrophic, 
depending on duration of symptoms and the location of the tumor [75, 116–118].
Radiological findings of ONSMs are variable (Figure 8). Computed tomography (CT) scanning 
characteristically shows fusiform or tubular expansion of the affected with a thickened and 
enhanced optic nerve sheath. Calcification of the sheath gives the classic “tram-track” sign. 
MRI is more accurate in soft tissue definition and proves that the ON parenchyma is of normal 
diameter. The ON is hypointense in T1-weighted images with the optic nerve sheath showing 
increased thickness and marked enhancement. In contrast to ONGs that show a smooth dural 
outline, ONSMs show rough outlines with thin extensions from the affected sheath [116–118].
Histopathologically (Figures 9 and 10), ONSMs have a meningotheliomatous or a mixed-type 
pattern. Psammoma bodies, which are hyalinized calcium deposits, are usually seen. Commonly, 
meningiomas spread to the extradural space invading the orbital tissue. Rarely, optic nerve, 
sclera, choroid, and retina are invaded [73, 80]. The diagnosis of ONSM primarily depends on 
the clinical presentation and imaging without the need for a biopsy in most cases [72].
Figure 8. Optic nerve sheath meningioma. T1-weighted MRI showing right oval orbital space occupying lesion encasing 
the mid and posterior right optic nerve.
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Figure 9. The histopathological appearance of the whorl-configuration of meningothelial cell proliferation (original 
magnification × 200 hematoxylin and eosin).
Figure 10. The appearance of the typical psammoma bodies in the same case of the optic nerve meningioma above 
(original magnification × 200 hematoxylin and eosin).
The only ONSMs related morbidity is visual loss from injury to the ipsilateral ON. These 
tumors typically do not cause neurological dysfunction or death. Therefore, the management 
of patients with ONSMs should be tailored to the individual case. Observation is suitable 
if there is no significant visual loss at presentation or follow-up, and there is no significant 
intracranial extension. Those patients can be observed twice per year with serial imaging [73]. 
ONSMs in pediatric population maybe more aggressive, and thus, they must be monitored 
with increased frequency [69].
Fractionated radiation therapy is the mainstay treatment of ONSM. More than 94% of patients’ 
vision has stabilized or improved. However, late radiation complications include radiation 
retinopathy and pituitary dysfunction [73]. Surgical excision is rarely advised because of the 
potential risk of significant visual deterioration. Indications for surgical intervention include 
intracranial extension of the tumor if there is a risk of contralateral ON involvement [69, 121].
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6. Secondary tumors of the optic nerve and sheath
Secondary tumors of the optic nerve are more common than the primary tumors [122]. 
These tumors can damage the ON by either infiltration, compression, or both. Secondary 
tumors include retinoblastoma, malignant melanoma of choroid, pseudotumor of the RPE, 
intracranial meningioma, metastatic carcinoma to the ON parenchyma or ONS, glioblastoma 
multiforme of the brain, lymphoma, or leukemia [73]. The clinical signs and management 
of secondary tumors depend on the particular tumor and the location of damage to the ON.
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